Furthermore, the administration of an anti-PD-1 monoclonal antibody together with anti-HER2 CAR-NK-92 cells for the treatment of glioblastoma has been reported in an abstract by Strassheimer et al. (187). Here, ERBB2 is linked to glioblastoma.